Blog
RSS FeedPosted by Michael Wonder on 13 Aug 2020
Seattle Genetics announces Tukysa (tucatinib) approved within months for all countries participating in FDA’s Project Orbis initiative
12 August 2020 - Australia joins U.S., Switzerland, Canada and Singapore in approval of Tukysa for the treatment of patients with ...
Posted by Michael Wonder on 13 Aug 2020
TGA approves new gene therapy from Novartis
13 August 2020 - Luxturna has been for the treatment of patients with inherited retinal dystrophy caused by pathological biallelic RPE65 ...
Posted by Michael Wonder on 12 Aug 2020
Australian scientists say too early to pick COVID-19 vaccine race winner in advice to Federal Government
13 August 2020 - The leading group of scientists advising the Federal Government says there is still no clear frontrunner in ...
Posted by Michael Wonder on 11 Aug 2020
Australia pins hopes on potential Oxford University COVID-19 vaccine
11 August 2020 - The Federal Government is positioning itself to secure and manufacture a COVID-19 vaccine in Australia, if ...
Posted by Michael Wonder on 11 Aug 2020
Local doctor may have breakthrough coronavirus cure
11 August 2020 - Local doctor Thomas Borody has found what may be a cheap and easy treatment for COVID-19 patients ...
Posted by Michael Wonder on 11 Aug 2020
Alkindi approved in Australia
10 August 2020 - Diurnal Group announces that Alkindi (hydrocortisone granules in capsules for opening) has been approved by the ...
Posted by Michael Wonder on 10 Aug 2020
Australian start-ups push for bigger role in vaccine making
9 August 2020 - An Australian startup racing to develop a successful coronavirus vaccine has urged the federal government to ...
Posted by Michael Wonder on 05 Aug 2020
Anavex Life Sciences receives TGA Special Access Scheme approval for Anavex 2-73 (blarcamesine) for Alzheimer’s disease patients
5 August 2020 - Compassionate use Special Access Scheme approval for Alzheimer’s patients to continue treatment with Anavex 2-73 (blarcamesine) after ...
Posted by Michael Wonder on 29 Jul 2020
TGA approves new medicine for basal cell carcinoma
29 July 2020 - Cemiplimab (Libtayo) has been provisionally registered by the TGA. ...
Posted by Michael Wonder on 27 Jul 2020
TGA approves Zeposia for patients with multiple sclerosis
27 July 2020 - Zeposia has been approved under the Black Triangle Scheme. ...
Posted by Michael Wonder on 23 Jul 2020
Delays to the commencement of certain medical device regulatory changes
23 July 2020 - The Governor-General in Council has made regulations which delay the commencement of a number of medical ...
Posted by Michael Wonder on 22 Jul 2020
Australia left in the dark as manufacturers race to make Oxford COVID-19 vaccine
22 July 2020 - Australia may have to compete with other nations to import supply of the University of Oxford's ...
Posted by Michael Wonder on 21 Jul 2020
TGA publishes AusPAR for Vemlidy
21 July 2020 - AusPAR published within days of its provisional registration; why do other take years? ...
Posted by Michael Wonder on 20 Jul 2020
Australian COVID researchers warn vaccines will have to be made overseas
20 July 2020 - Researchers at Monash University say if their COVID-19 vaccine is successful they will be forced to ...
Posted by Michael Wonder on 16 Jul 2020
Actual and potential harm caused by medical software
16 July 2020 - TGA publishes a rapid literature review of safety and performance issues. ...